These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38415308)

  • 21. Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia.
    Reuben J; Donegan N; Wortmann G; DeBiasi R; Song X; Kumar P; McFadden M; Clagon S; Mirdamadi J; White D; Harris JE; Browne A; Hooker J; Yochelson M; Walker M; Little G; Jernigan G; Hansen K; Dockery B; Sinatro B; Blaylock M; Harmon K; Iyengar P; Wagner T; Nelson JA;
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):921-929. PubMed ID: 28615088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. European survey of management of patients with multidrug-resistant organisms in rehabilitation facilities.
    Doherty A; McNicholas S; Burger H; Boldrini P; Delargy M
    Eur J Phys Rehabil Med; 2019 Aug; 55(4):418-423. PubMed ID: 30781935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review.
    Cleland H; Tracy LM; Padiglione A; Stewardson AJ
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):82. PubMed ID: 35698209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct Origins and Transmission Pathways of
    Lapp Z; Octaria R; O'Malley SM; Nguyen TN; Wolford H; Crawford R; Moore C; Snippes Vagnone P; Noel D; Duffy N; Pirani A; Thomas LS; Pattee B; Pearson C; Bulens SN; Hoffman S; Kainer M; Anacker M; Meek J; See I; Gontjes KJ; Chan A; Lynfield R; Maloney M; Hayden MK; Snitkin E; Slayton RB
    J Clin Microbiol; 2023 Aug; 61(8):e0025923. PubMed ID: 37439675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal Design of Paired Built Environment Interventions for Control of MDROs in Acute Care and Community Hospitals.
    Squire MM; Sessel GK; Lin G; Squire EN; Igusa T
    HERD; 2021 Apr; 14(2):109-129. PubMed ID: 33375862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.
    Lee BY; Bartsch SM; Wong KF; McKinnell JA; Slayton RB; Miller LG; Cao C; Kim DS; Kallen AJ; Jernigan JA; Huang SS
    Am J Epidemiol; 2016 Mar; 183(5):471-9. PubMed ID: 26861238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compliance with statewide regulations for communication of patients' multidrug-resistant organism and Clostridium difficile status during transitions of care.
    Ellingson KD; Noble BN; Tran D; Buser GL; Pfeiffer CD; Cassidy PM; Pierce R; Beldavs ZG; Furuno JP
    Am J Infect Control; 2020 Apr; 48(4):451-453. PubMed ID: 31604624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of ethylene-oxide gas sterilisation to terminate multidrug-resistant bacterial outbreaks linked to duodenoscopes.
    Muscarella LF
    BMJ Open Gastroenterol; 2019; 6(1):e000282. PubMed ID: 31423318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of tailored screening for multidrug-resistant organisms upon admission to an intensive care unit in the United Arab Emirates.
    Park S; Kim H; Gatchalian KK; Oh H
    Antimicrob Resist Infect Control; 2023 Nov; 12(1):135. PubMed ID: 38012753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers and facilitators to healthcare workers' adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis.
    Houghton C; Meskell P; Delaney H; Smalle M; Glenton C; Booth A; Chan XHS; Devane D; Biesty LM
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013582. PubMed ID: 32315451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional transmission patterns of carbapenemase-producing Enterobacterales: A healthcare network analysis.
    Tadese BK; Fujimoto K; DeSantis SM; Mgbere O; Darkoh C
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):453-459. PubMed ID: 35450553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term acute care hospitals.
    Munoz-Price LS
    Clin Infect Dis; 2009 Aug; 49(3):438-43. PubMed ID: 19548836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving hospital hygiene to reduce the impact of multidrug-resistant organisms in health care--a prospective controlled multicenter study.
    Gerlich MG; Piegsa J; Schäfer C; Hübner NO; Wilke F; Reuter S; Engel G; Ewert R; Claus F; Hübner C; Ried W; Flessa S; Kramer A; Hoffmann W
    BMC Infect Dis; 2015 Oct; 15():441. PubMed ID: 26493394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (CRAB) in Mechanically Ventilated COVID-19 Patients and Impact of Infection Control Measures on Reducing CRAB Circulation during the Second Wave of the SARS-CoV-2 Pandemic in Milan, Italy.
    Mangioni D; Fox V; Chatenoud L; Bolis M; Bottino N; Cariani L; Gentiloni Silverj F; Matinato C; Monti G; Muscatello A; Teri A; Terranova L; Piatti A; Gori A; Grasselli G; Stocchetti N; Alteri C; Bandera A
    Microbiol Spectr; 2023 Mar; 11(2):e0020923. PubMed ID: 36976013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in infection control and diagnostic measures for multidrug-resistant organisms in the tristate area of France, Germany and Switzerland in 2019 - survey results from the RH(E)IN-CARE network.
    Tschudin-Sutter S; Lavigne T; Grundmann H; Rauch J; Eichel VM; Deboscker S; Jaulhac B; Mutters NT
    Swiss Med Wkly; 2021 Mar; 151():w20454. PubMed ID: 33705560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Active Rapid Molecular Screening and IPC Interventions on Carbapenem-Resistant
    Yang S; He L; Li K; Yu X; Ni L; Hu L; Guo J; Biskup E; Tang L; Wu W
    Infect Drug Resist; 2023; 16():1039-1048. PubMed ID: 36845019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling spread of KPC-producing bacteria in long-term acute care hospitals in the Chicago region, USA.
    Haverkate MR; Bootsma MC; Weiner S; Blom D; Lin MY; Lolans K; Moore NM; Lyles RD; Weinstein RA; Bonten MJ; Hayden MK
    Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1148-54. PubMed ID: 26204992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Data-Driven Framework for Identifying Intensive Care Unit Admissions Colonized With Multidrug-Resistant Organisms.
    Çaǧlayan Ç; Barnes SL; Pineles LL; Harris AD; Klein EY
    Front Public Health; 2022; 10():853757. PubMed ID: 35372195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outbreak of carbapenem-resistant enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions.
    Chitnis AS; Caruthers PS; Rao AK; Lamb J; Lurvey R; Beau De Rochars V; Kitchel B; Cancio M; Török TJ; Guh AY; Gould CV; Wise ME
    Infect Control Hosp Epidemiol; 2012 Oct; 33(10):984-92. PubMed ID: 22961017
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.